Asterion Limited

United Kingdom

Create a watch for Asterion Limited
Total IP 23
Total IP Rank # 65,161
IP Activity Score 0/5.0    0
IP Activity Rank # 1,707,690
Parent Entity Fusion IP Sheffield Limited
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

3 0
0 0
19 0
1
 
Last Patent 2019 - Fusion polypeptide comprising th...
First Patent 2001 - Binding agents: chimeric ligand/...
Last Trademark 2007 - PROFUSE
First Trademark 2007 - PROFUSE

Industry (Nice Classification)

Latest Inventions, Goods, Services

2016 Invention Fusion polypeptide comprising the extracellular binding domain of growth hormone receptor. The i...
Invention Fusion polypeptide comprising the extracellular binding domain of growth hormone receptor. The in...
Invention Growth hormone fusion proteins with growth hormone receptor agonist activity. We disclose growth ...
2012 Invention Growth hormone fusion proteins. We disclose growth hormone [GH] fusion proteins that have increas...
Invention Growth hormone receptor antagonists. We disclose growth hormone fusion proteins that have increas...
Invention Modified receptor fusion proteins. We disclose growth hormone fusion proteins that have increased...
2010 Invention Interferon lambda fusion polypeptides. The disclosure relates to interferon lambda fusion polype...
2009 Invention Glp-1 fusion polypeptides. We describe nucleic acid molecules that encode fusion polypeptides co...
Invention Glp-1 fusion polypeptides. We describe nucleic acid molecules that encode fusion polypeptides com...
Invention Interleukin fusion polypeptides. The disclosure relates to interleukin fusion polypeptides and di...
Invention Insulin fusion polypeptides. We disclose insulin fusion polypeptides and dimers; nucleic acid mo...
Invention Insulin fusion polypeptides. We disclose insulin fusion polypeptides and dimers; nucleic acid mol...
Invention Thyroid stimulating hormone fusion proteins. We disclose TSH fusion proteins comprising TSHα and/...
Invention Modified fusion polypeptides. Chimeric polypeptides wherein the polypeptides comprise a modified...
Invention Modified linkers. We describe modified peptide linkers that function to link at least first and ...
Invention Modified linkers. We describe modified peptide linkers that function to link at least first and s...
2008 Invention Peptide fusion proteins. We disclose fusion proteins comprising a peptide comprising a binding do...
Invention Prolactin fusion proteins. We disclose prolactin fusion proteins that have agonist or antagonist ...
Invention Modified growth hormone polypeptides. We describe modified growth hormone fusion proteins and dim...
Invention Insulin-like growth factor fusion proteins. This disclosure relates to insulin-like growth facto...
Invention Interferon fusion proteins. The disclosure relates to interferon fusion polypeptides and dimers;...
Invention Interferon fusion proteins. The disclosure relates to interferon fusion polypeptides and dimers; ...
Invention Insulin-like growth factor fusion proteins. This disclosure relates to insulin-like growth factor...
Invention Erythropoietin. This disclosure relates to erythropoietin (EPO) fusion polypeptides; nucleic aci...
Invention Erythropoietin fusion proteins. This disclosure relates to erythropoietin (EPO) fusion polypeptid...
Invention Granulocyte colony stimulating factor. We disclose granulocyte colony stimulating factor fusion ...
Invention Granulocyte colony stimulating factor. We disclose granulocyte colony stimulating factor fusion p...
Invention Leptin fusion proteins. The disclosure relates to leptin fusion polypeptides; nucleic acid molec...
Invention Leptin fusion proteins. The disclosure relates to leptin fusion polypeptides; nucleic acid molecu...
Invention Fusion protein comprising growth hormone and growth hormone receptor. Agents which bind to cell s...
Invention Growth hormone fusion proteins. We disclose growth hormone fusion proteins that have increased in...
2007 Invention Growth factor. We describe a chimeric protein comprising a growth hormone polypeptide linked to ...
Invention Growth factor. We describe a chimeric protein comprising a growth hormone polypeptide linked to a...
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
Invention Polypeptide antagonist. We describe a circularly permuted growth hormone polypeptide antagonist;...
Invention Polypeptide antagonist. We describe a circularly permuted growth hormone polypeptide antagonist; ...
Invention Leptin ligand. We describe ligands that specifically bind leptin and/or the leptin receptor there...
2006 Invention Polypeptide variants. The invention relates to the provision of oligomeric polypeptides (dimers,...
2005 Invention Linkers. We disclose therapeutic polypeptides comprising at least two domains capable of binding...
Invention Linkers. We disclose therapeutic polypeptides comprising at least two domains capable of binding ...
2004 Invention Cytokine variant polypeptides. We describe modified cytokine ligand polypeptides comprising a mo...
Invention Cytokine variant polypeptides. We describe modified cytokine ligand polypeptides comprising a mod...
Invention Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylp...
Invention Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosyl...
2003 Invention Fusion protein comprising growth hormone and growth hormone receptor. This invention relates to a...
2002 Invention Modified growth hormone fusion polypeptides. The invention relates to chimeric polypeptides where...
Invention Growth hormone fusion protein. The invention relates to chimeric polypeptides wherein said polype...
Invention Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinos...